
Realty Income (O)
NYSEReal EstateReit - RetailSnapshot 2026-07-07
Reading O? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track O free→
NYSEReal EstateReit - RetailSnapshot 2026-07-07
Reading O? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track O free→QuarterlyIQ Insights · O
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $64.00. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $64 O trades at 16× p/ffo, in line with its 13× p/ffo peer median — but our blended $74 fair value sits above the price. We hold it with medium confidence: our number sits above the analyst range. Analysts target $65–$71. Note: our $74 fair value sits above the entire analyst range ($65–$71). Not investment advice.
$65.00 – $70.75 (median $67.50) · 8 analysts · as of 2026-07-06
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $67.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $175.39 | — | — | Analyst | high |
| dcf fcff | 12M | $201.65 | — | — | Analyst | high |
| graham number | 12M | $35.24 | — | — | TTM | high |
| Peer P/FCF | 12M | $98.33 | 23.3 | 4.22 | TTM | high |
| Peer P/FFO | 12M | $51.99 | 13.2 | 3.93 | TTM | high |
| Peer P/S | 12M | $49.85 | 7.9 | 6.33 | TTM | high |
| PEG | 12M | $42.60 | 34.1 | 1.25 | TTM | high |
| residual income | 12M | $34.86 | — | — | TTM | high |
| Own P/E history | 12M | $62.72 | 50.1 | 1.25 | TTM | high |
| triangulated | 12M | $16.43 | 13.2 | 1.24 | Triangulated | high |
| Peer P/FFO | 3Y | $73.13 | 13.2 | 5.53 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $55.10 | 7.9 | 7.00 | Analyst | medium |
| PEG | 3Y | $60.87 | 34.1 | 1.79 | Analyst | medium |
| Own P/E history | 3Y | $89.62 | 50.1 | 1.79 | Analyst | medium |
| Peer P/FFO | 5Y | $91.79 | 13.2 | 6.94 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $58.83 | 7.9 | 7.47 | Analyst | high |
| PEG | 5Y | $64.98 | 34.1 | 1.91 | Analyst | high |
| Own P/E history | 5Y | $95.67 | 50.1 | 1.91 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.